Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Braud

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Immunology|May 1, 1997
The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9V Braud, E Y Jones, A McMichael
Proceedings of the National Academy of Sciences of the United States of America|January 9, 1996
Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytesK Toshitani, V Braud, M J Browning, et al.
Human Immunology|October 1, 1994
Susceptibility to alloimmunization to platelet HPA-1a antigen involves TAP1 polymorphismV Braud, D Chevrier, A Cesbron, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|October 1, 1993
Lack of binding of peptides carrying the human platelet antigen 1 (HPA-1) dimorphism to purified HLA-DRw52a moleculesV Braud, N Valentin, J Choppin, et al.
European Journal of Immunology|January 1, 1997
The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cellsV Cerundolo, A Benham, V Braud, et al.
Transplantation|August 15, 1995
Effects of MHC-encoded TAP1 and TAP2 gene polymorphism and matching on kidney graft rejectionD Chevrier, M Giral, V Braud, et al.
The Journal of Experimental Medicine|December 1, 1995
HLA-A2 subtypes are functionally distinct in peptide binding and presentationD Barouch, T Friede, S Stevanović, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Immunology|May 1, 1997
The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9V Braud, E Y Jones, A McMichael
Proceedings of the National Academy of Sciences of the United States of America|January 9, 1996
Expression of a single-chain HLA class I molecule in a human cell line: presentation of exogenous peptide and processed antigen to cytotoxic T lymphocytesK Toshitani, V Braud, M J Browning, et al.
Human Immunology|October 1, 1994
Susceptibility to alloimmunization to platelet HPA-1a antigen involves TAP1 polymorphismV Braud, D Chevrier, A Cesbron, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|October 1, 1993
Lack of binding of peptides carrying the human platelet antigen 1 (HPA-1) dimorphism to purified HLA-DRw52a moleculesV Braud, N Valentin, J Choppin, et al.
European Journal of Immunology|January 1, 1997
The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cellsV Cerundolo, A Benham, V Braud, et al.
Transplantation|August 15, 1995
Effects of MHC-encoded TAP1 and TAP2 gene polymorphism and matching on kidney graft rejectionD Chevrier, M Giral, V Braud, et al.
The Journal of Experimental Medicine|December 1, 1995
HLA-A2 subtypes are functionally distinct in peptide binding and presentationD Barouch, T Friede, S Stevanović, et al.
Pageof 1